CVS/Caremark merger wins ISS approval

THE CVS/CAREMARK merger proposal announced in November by Thomas M. Ryan, left, president and CEO of CVS, and Mac Crawford, his  Caremark Rx counterpart, has won the endorsement of advisory service ISS. /
THE CVS/CAREMARK merger proposal announced in November by Thomas M. Ryan, left, president and CEO of CVS, and Mac Crawford, his Caremark Rx counterpart, has won the endorsement of advisory service ISS. /
NASHVILLE, Tenn. – Caremark Rx. Inc. (NYSE: CMX) today announced that Institutional Shareholder Services, an independent proxy voting advisory service, is now advising clients to support Caremark’s pending merger with CVS Corp. (NYSE: CVS). ISS, whose clients include hundreds of institutional investors, mutual funds, money managers and other fiduciaries, previously had advised its clients against…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -